Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

ProShares Ultra Nasdaq Biotechnology (BIB)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
48.94 -1.18    -2.35%
- Closed. Currency in USD ( Disclaimer )
After Hours
48.94
0.00
0.00%
- Real-time Data
Type:  ETF
Market:  United States
Issuer:  ProShares
Asset Class:  Equity
  • Volume: 28,235
  • Bid/Ask: 46.61 / 51.37
  • Day's Range: 47.98 - 49.75
ProShares Ultra Nasdaq Biotechnology 48.94 -1.18 -2.35%

BIB Recent Sentiments

 
Information on users’ sentiments for the ProShares Ultra Nasdaq Biotechnology ETF, which are displayed both on charts of different periods of time and on a detailed table.
Start Date Username Call Open Rate End Date Chg. %
Jan 12, 2024 Erkan Erkan   59.69 Feb 02, 2024 @ 57.06 -4.41%
Nov 25, 2023 Ana Luisa Cerda...   44.08 Nov 30, 2023 @ 43.94 -0.32%
Aug 26, 2022 Andrey Sokolin   52.82 Sep 16, 2022 @ 51.88 -1.78%
Aug 03, 2022 שלמה עזרא   54.91 Aug 26, 2022 @ 52.08 -5.15%
Apr 28, 2022 Kfir Nahum   50.00 May 20, 2022 @ 47.54 +4.92%
Jun 07, 2021 Руки ВВЕРХ Жук   91.80 Jul 02, 2021 @ 99.80 +8.71%
Mar 18, 2021 Gerardo Puglisi   91.25 Apr 09, 2021 @ 81.57 -10.61%
Feb 12, 2021 Aminadab Garcia   108.35 Feb 12, 2021 @ 108.35 0.00%
Feb 02, 2021 Артур Меркулов   100.42 Feb 26, 2021 @ 91.87 -8.51%
Jan 19, 2021 Евгений Капралов   101.29 Feb 12, 2021 @ 108.82 +7.43%
Jan 15, 2021 Flavio Man   98.13 Feb 05, 2021 @ 106.98 -9.02%
Jan 15, 2021 Antonio Gandolfo   97.26 Feb 05, 2021 @ 106.98 +9.99%
Jan 06, 2021 Pablo Nouhet   85.23 Jan 12, 2021 @ 93.66 +9.89%
Jan 04, 2021 Robert Gysemans   86.14 Jan 29, 2021 @ 96.92 +12.51%
Dec 17, 2020 Antonio Gandolfo   89.02 Dec 22, 2020 @ 92.83 +4.28%
Nov 11, 2020 Александр Бестужев   72.40 Dec 04, 2020 @ 82.17 -13.49%
Oct 30, 2020 Jagdish Ramnani   64.80 Nov 20, 2020 @ 72.74 +12.25%
Sep 15, 2020 evan huq   71.49 Oct 09, 2020 @ 77.34 +8.18%
Sep 14, 2020 Jose Carreras   69.16 Oct 02, 2020 @ 67.73 -2.07%
Jul 22, 2020 רפאל אגיב   78.03 Aug 14, 2020 @ 68.41 -12.33%
Jun 17, 2020 Nelslibmar Rossenny...   69.01 Jul 10, 2020 @ 75.06 +8.77%
Jun 09, 2020 Jonathan Gette   69.18 Jul 03, 2020 @ 74.30 +7.40%
May 21, 2020 liran yagen   68.76 Jun 12, 2020 @ 63.93 -7.02%
May 20, 2020 eli huri   69.21 Jun 12, 2020 @ 63.93 -7.63%
Apr 14, 2020 Angel Fernandez   54.90 May 08, 2020 @ 64.70 -17.85%
Mar 09, 2020 levy meir   51.43 Apr 03, 2020 @ 44.97 +12.56%
Feb 12, 2020 AXEL Alex   63.50 Mar 06, 2020 @ 58.35 -8.11%
Dec 16, 2019 Antonio Gandolfo   63.03 Jan 10, 2020 @ 61.55 -2.35%
Oct 11, 2019 levy meir   43.22 Nov 01, 2019 @ 51.35 -18.81%
May 30, 2019 Antonio Gandolfo   45.35 Jun 20, 2019 @ 52.61 +16.01%
Apr 30, 2019 Antonio Gandolfo   49.93 May 24, 2019 @ 47.62 -4.63%
Mar 06, 2019 NoMo Lim   53.83 Mar 29, 2019 @ 55.48 +3.07%
Mar 01, 2019 Tatiana Uribe Mejía   58.82 Mar 22, 2019 @ 52.03 -11.54%
Feb 05, 2019 Gary Chang   54.84 Feb 07, 2019 @ 51.31 -6.44%
Jan 07, 2019 Diogo Lino   50.31 Feb 07, 2019 @ 47.69 -5.21%
Dec 27, 2018 Ihab Rida   37.96 Dec 27, 2018 @ 40.52 +6.74%
Nov 20, 2018 HongBae Park   48.05 Dec 20, 2018 @ 47.69 +0.75%
Nov 16, 2018 valerij andrijchuk   49.73 Dec 16, 2018 @ 47.69 +4.10%
Oct 30, 2018 GandoUY   49.15 Nov 29, 2018 @ 47.69 -2.97%
Oct 17, 2018 Alexios Vasileiadis   60.59 Nov 16, 2018 @ 47.69 +21.29%
Aug 03, 2018 Daniel Gorski   65.38 Aug 13, 2018 @ 64.22 -1.77%
Jul 12, 2018 GandoUY   65.60 Aug 11, 2018 @ 64.22 -2.10%
Jun 11, 2018 GandoUY   57.46 Jul 11, 2018 @ 64.14 +11.63%
May 22, 2018 Amy Leung   54.63 Jun 21, 2018 @ 60.07 +9.96%
Apr 30, 2018 Absalon Joel Sosa...   53.46 May 30, 2018 @ 55.92 +4.60%
Apr 15, 2018 Chetan Woodun   53.70 May 15, 2018 @ 54.00 +0.56%
Feb 26, 2018 GandoUY   59.68 Mar 28, 2018 @ 54.18 -9.22%
Feb 19, 2018 GandoUY   59.15 Feb 19, 2018 @ 59.15 0.00%
Feb 09, 2018 михаил шошин   51.66 Mar 11, 2018 @ 63.27 +22.47%
Jan 17, 2018 GandoUY   60.83 Feb 16, 2018 @ 59.15 -2.76%
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

BIB Comments

Write your thoughts about ProShares Ultra Nasdaq Biotechnology
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email